Antelope Technologies and Transmeta Announce Collaboration on Innovative Mobile Computer.

Business Editors/High-Tech Writers

Antelope Technologies Corporation and Transmeta Corporation (Nasdaq:TMTA) today announced that Antelope's Mobile Computer Core (MCC) will incorporate Transmeta's Crusoe TM5800 processor.

Antelope, of Littleton, Colo., has signed a licensing agreement with IBM for "Meta Pad," a portable computing device that transforms in seconds into a personal digital assistant (PDA), desktop, laptop, tablet or wearable computer without having to be rebooted.

Antelope has secured a ten-year license agreement to manufacture and market its own version of the device, the Mobile Computer Core, using Meta Pad technology, developed by IBM. First production models of Antelope's MCC will be available this September.

"Antelope's MCC design, based on the IBM Meta Pad, is leading the way toward an ultra personal style of computing, where you can take all of your data with you anytime," said Matthew Perry, president and chief executive officer, Transmeta Corporation. "The MCC's ability to transform into a PDA, notebook or desktop form factor will free users from the need to synchronize several different devices, while providing the full Windows XP experience with Transmeta's Crusoe processor."

"Transmeta is a leader in power-efficient, high performance microprocessors," said Kenneth Geyer, president of Antelope Technologies. "The Crusoe microprocessor is instrumental in providing our Mobile Computer Core with long battery life, low heat output and high performance operation."

"Informal industry studies are telling us this technology can save about $16,000 per employee per year in time spent transferring information from field computers to desktops," said Geyer. "Or, in terms of productivity, it translates into a savings of about 48 employee days per year."

The MCC is centered around a processor, internal battery, data storage and computer software applications. An additional power supply, display, communications and input/output connectors are accessories, allowing the device to be transformed into a handheld, desktop, laptop, tablet or wearable computer in seconds, without rebooting or synching. It can run a variety of operating systems that share the same data, including full Windows XP, Windows 2000 or Linux, allowing users to run any application that runs on those operating systems.

Antelope Mobile Computer Core Specifications

-- Dimensions: 3" x 5" x 0.75"

-- Weight: 9.1 ounces

-- Hard drive: 10GB

-- RAM: 256MB, future expansion to 512MB

-- Processor: 800MHz Transmeta Crusoe TM5800

-- Video Adapter: Silicon Motion Lynx 721 8MB 3D graphics chipset

-- Operating Systems: Windows XP, Windows 2000 or Linux

About Antelope Technologies

Antelope Technologies is a Colorado corporation that designs, manufactures, and markets mobile computing technologies. Based in Littleton, Colorado, the company integrates these technologies for military, medical, industrial, security and law enforcement institutions worldwide. For more information about Antelope Systems, visit http://www.antelopetech.com or contact Anna Cole at [phone] or [e-mail].

About Transmeta Corporation

Transmeta develops and sells software-based microprocessors and develops additional hardware and software technologies that enable computer manufacturers to build computers that simultaneously offer long battery life, high performance and x86 compatibility. Transmeta's family of Crusoe microprocessors is targeted at the notebook, Tablet PC and Internet appliance segments of the mobile Internet computer market, as well as a range of embedded applications. For more information visit http://www.transmeta.com.

Windows is a registered trademark of Microsoft Corporation in the U.S. and other countries used under license.

Transmeta and Crusoe are trademarks and/or registered trademarks of Transmeta Corporation in the United States and/or other countries. All other trademarks are the properties of their respective owners.

Cautionary Statement

This release contains forward-looking statements regarding future events or the future financial performance of Transmeta Corporation, which statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that these forward-looking statements are only predictions, which may differ materially from actual results or future events. All such forward-looking statements are based upon our current expectations but involve inherent risks and uncertainties. Such forward-looking statements speak only as of the date of this release, and the company will not necessarily provide updates of its forward-looking projections or forecasts.

Risks and uncertainties that may have material effects on our future performance include general economic conditions, including the recent significant slowdown in the technology sector and semiconductor industry, the timing, rescheduling or cancellation of significant customer orders, potential fluctuations in our quarterly results, dependence on increasing demand for our Crusoe products, difficulties in developing or manufacturing new products in a timely and cost effective manner, market acceptance of our new products and of our customers' systems using our products, the growth of emerging markets that we are addressing, our customer concentration, the loss of revenue if a major customer were to cancel, reduce or delay a product order, inventory write-offs from a failure to forecast product demand accurately, our dependence on third parties for sourcing materials and providing manufacturing services, delays in product deliveries as we transition to smaller geometry process technologies, intense competition from Intel and others, rapid technological change, patents and intellectual property rights, volatility of our stock price, and the cyclical nature of the semiconductor market. We urge investors to review our regular filings with the Securities and Exchange Commission, including specifically our most recently filed Form 10-Q, which identifies and describes many of these and other important risk factors that could cause our actual results to differ from those contained in these forward-looking statements.